Sarama Resources Completes Strategic Mt Venn Acquisition

ASX: ATX

Targeting Pancreatic Cancer and Beyond: Amplia Therapeutics (ASX:ATX) Pancreatic cancer is one of the hardest cancers to treat, but Amplia Therapeutics (ASX:ATX | OTCQB:INNMF) may have found a way to help. Their drug, narmafotinib, works by breaking down the tough fibrous shield around tumours, letting chemotherapy do its job better. Join this investor webinar to hear how the science is playing out in real trials, what the path to FDA approval looks like, and where the company is headed next, including new work in ovarian cancer and a promising new class of cancer drugs called kRAS inhibitors.